Title: A Correlative Study of Biochemical, Virological & Histological Parameters of HBV Infection in HIV/HBV Co-Infection

Authors: S K Singh, Sarvinder Singh, Bhaskar Shahbabu, Vani Singh

 DOI:  https://dx.doi.org/10.18535/jmscr/v5i5.09

Abstract

Introduction: In the setting of HBV-HIV coinfections, serial monitoring of ALT alone may not predict the severity of HBV disease. This study aims at studying the correlation between ALT, Viral load and the histological progression of HBV related infection in HIV positive individuals.

Methods: The study included 30 ART naïve patients with HIV-HBV co-infection as cases and 30 incidentally detected mono infected (HBsAg positive) as control.  All the patients had undergone viral serology, CD4 count and HBV DNA viral load. Selected patients based on HBeAg and HBV-DNA level were subjected to liver biopsy. Liver biopsy was scored by applying Knodell criteria [HAI].

Results-The sero-prevalence rate of HBV in HIV population in our study was 13.3%. HBeAg positivity is 10.7 times (95% CI: 2.1-53.3) more among the cases than the controls and it was statistically significant. The median ALT level in cases was 34.5 IU/L while in control group it was 77.0 IU/L. The median HBV DNA level in cases was 5.7x105copies/ml while in control group, it was 7.3x103 copies/ml. The number of patients qualified for need of liver biopsy based on HBeAg positivity and HBV DNA levels were 13 in cases and 5 among controls. The median HAI score in cases was 7.0, which was significantly more than among controls.

Conclusion: Treatment modality should be devised based on HBV plasma viral load, HBeAg status and liver biopsy and not based solely upon ALT.

Keywords: HBV-HIV Coinfection. Knodell’s Criteria, Liver biopsy score, Histologic Activity Index, HBV plasma viral load, ALT monitoring.

References

1.      McGovern BH. The epidemiology, natural history and prevention of hepatitis B: implications of HIV co-infection. Antivir Ther  2007; 12(Suppl 3): H3–H13.

2.      Alter MJ. Epidemiology of viral hepatitis and HIV co-infection. J Hepatol 2006; 44(1 Suppl ): S6–S9.

3.      PalellaFJJr, Baker RK, Moorman AC, ChmielJS, Wood KC, Brooks JT, et al. Mortality in the highly active antiretroviral therapy era: changing causes of death and disease in the HIV outpatient study. J Acquir Immune DeficSyndr 2006; 43: 27–34.

4.      Liang, T. Jake, and Marc Ghany. "Hepatitis B E Antigen — The Dangerous Endgame Of Hepatitis B". New England Journal of Medicine 347.3 (2002): 208-210. Web.

5.      Gupta, Swati, and Sarman Singh. "Occult Hepatitis B Virus Infection In ART-Naive HIV-Infected Patients Seen At A Tertiary Care Centre In North India". BMC Infectious Diseases 10.1 (2010).

6.      Bodsworth NJ, Cooper DA, Donovan B. The influence of human immunodeficiency virus type 1 infection on the development of the hepatitis B carrier state. J Infect Dis 1991; 163: 1138–1140

7.      Chen, Chien-Jen, Uchenna H. Iloeje, and Hwai-I. Yang. "Long-Term Outcomes In Hepatitis B: The REVEAL-HBV Study". Clinics in Liver Disease 11.4 (2007): 797-816. 

8.      Chan, H. "Viral Genotype And Hepatitis B Virus DNA Levels Are Correlated With Histological Liver Damage In Hbeag-Negative Chronic Hepatitis B Virus Infection". The American Journal of Gastro-enterology 97.2 (2002): 406-412. Web.

9.      Nabuco, Leticia Cancella et al. "HBV-DNA Levels In Hbsag-Positive Blood Donors And Its Relationship With Liver Histology". Journal of Clinical Gastroen-terology 41.2 (2007): 194-198. Web.

Corresponding Author

S K Singh

Lt Col. (Medical Specialist)

Military Hospital Namkum, India